Agreed. Revenue missed by 0.3M. Stock dropped from high a couple of weeks ago, by approximately 15%. Absurd. Informatica will return and go up by 15% to 50 above where it was. Insiders at Informatica, are capable of doing their jobs but incapable of seeing where their company stock is going. I wrote things like this when INFA was at 12. Informatica is the glue that binds systems together, at large companies, in addition to their other functionality. Large companies have a choice of rewrites or using INFA software. 50 by 12/31/15.
I've posted this at various prices. Informatica has always been and is the glue that connects systems running on different hardware at large companies. It is not cost justified for the companies to rewrite legacy systems so they pay the lease price to connect the data. I've posted this numerous times and Informatica fall first and then rises - always. Expect 40-42 at some point in 6 months. It's 36 + now on June 2 2014.
Expecting Tuesday open to be much lower than Friday close. Any ideas on how low it will open?
I heard a rumor that when JCP eventually goes to 10, that the idiots at Wells Fargo will issue an apology for being stupid. I don't know if it's true or not, but when it gets to 10, I really would like to see that apology.
Insider selling = NOTHING. The correlation between insider selling and 3 - 6 month price change is 0. That's zero for all the amateurs who understand nothing. People sell because they want to buy yachts, or houses or pay for college educations. Lemmings follow other lemmings and there is a short term drop followed by a return to normalcy. The stock price is below what it should be and what it was. I'll write again September when by which time it will be back to where it was or higher.
My short term target is 41. Based on rumors I've heard, the earnings are in line with predicted earnings or slightly better than predicted earnings. Price should begin rising as soon as earnings are released.
Maybe he's buying a yacht. Maybe he is paying tuition for his extended family. Traditionally insider selling is meaningless whereas insider buying has been correlated positively to future price increases.
I read some negatives, some positives but overall a lot of positives. Obviously the negatives convinced more people than the positives. I did not see the specifics that you mentioned. Can you tell me precisely where they are?
I wish that I had the money to buy more. There is nothing wrong with this company. It is a very very low volume trader and it will go to 30 and it won't take that long. It's just a few sellers that have brought the price down in the short term. Company is stable, competitive and will be back to 30.
Fabulous buy under 29. GLT would be a great buy at 29.50, but at under 29 it's a fantastic buy. Small volume and often 6 cent spread, but most buys and sells in between bid and ask. Declined on small volume. Any decent buying will make price soar.
News article today - BAC added $1 billion to their estimate of legal liability. Stock price will drop today. No one can expect it to rise today!
A 28 million dollar contract was added to sales today. The gross income statement on this site says that the annual revenue is 21.44 billion. Now 28 million only increases the estimated revenue (if no growth) by a faction of approximately .0013 but still it's a 28 million dollar contract and it could lead to other contracts. This happened today and the only comment on the board regarding XRX is that XRX employees don't like Burns.
My question was not meant to be loaded; it was meant to elicit responses hoping that one of them would give me more information than I already had. Would you have preferred that I listed all I knew about this product and then asked posters to tell me any other information that I had not listed. I was starting a meaningful discussion unlike 75% of the garbage I read here. No, I'm not a newbie and I'm probably a lot smarter than 95% of the posters here.I'm looking for additional information. For example I want to know if there is a problem measuring the levels of a diabetic after a dose or should I say breath of this product. Maybe this is not a problem or maybe it is or maybe it's not being discussed yet; but conceptually it should be a problem or a problem solved. If you want to carry on a meaningful discussion then that's okay with me, if not then ignore me.
Listen idiot, many posters have written very useful information about Afrezza and the previous attempts to produce an inhalant that controlled diabetes. There are traders who have medical knowledge gained as physicians, pharmacists and research scientists, and some who have read articles that I have not found. I asked a general question to elicit responses. That is the purpose of this board. In the future you could do me a great favor and not post any responses to questions I ask or comments I make, since your comments are useless and waste my time.
Why did the previous inhalant products fail and what is the different about Afrezza? What objections did the FDA have that they stated in their letters to MKND?